Low risk of thrombosis and serious embolic events despite low-intensity anticoagulation. Experience with 1,004 Medtronic Hall valves

Circulation

Volumn 78, Issue 3 II SUPPL., 1988, Pages

  Butchart, E G ^a   Lewis, P A ^a   Grunkemeier, G L ^a   Kulatilake, N ^a   Breckenridge, I M ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ADULT; AGED; BLEEDING; CLINICAL TRIAL; DRUG THERAPY; FEMALE; HEART VALVE PROSTHESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDTRONIC HALL VALVE PROSTHESIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOEMBOLISM; THROMBOSIS;

ACTUARIAL ANALYSIS; EMBOLISM; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEART VALVES; HUMAN; MIDDLE AGE; POSTOPERATIVE COMPLICATIONS; THROMBOEMBOLISM; THROMBOSIS; WARFARIN;

EID: 0006126942     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)